These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17083604)

  • 1. Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells.
    Naujokat C; Berges C; Höh A; Wieczorek H; Fuchs D; Ovens J; Miltz M; Sadeghi M; Opelz G; Daniel V
    Immunology; 2007 Jan; 120(1):120-32. PubMed ID: 17083604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibition suppresses essential immune functions of human CD4+ T cells.
    Berges C; Haberstock H; Fuchs D; Miltz M; Sadeghi M; Opelz G; Daniel V; Naujokat C
    Immunology; 2008 Jun; 124(2):234-46. PubMed ID: 18217957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib.
    Subklewe M; Sebelin-Wulf K; Beier C; Lietz A; Mathas S; Dörken B; Pezzutto A
    Hum Immunol; 2007 Mar; 68(3):147-55. PubMed ID: 17349869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.
    Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
    J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
    Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
    Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithymocyte globulins suppress dendritic cell function by multiple mechanisms.
    Naujokat C; Berges C; Fuchs D; Sadeghi M; Opelz G; Daniel V
    Transplantation; 2007 Feb; 83(4):485-97. PubMed ID: 17318082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of valproic acid on dendritic cells function.
    Frikeche J; Simon T; Brissot E; Grégoire M; Gaugler B; Mohty M
    Immunobiology; 2012 Jul; 217(7):704-10. PubMed ID: 22209114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells.
    Straube C; Wehner R; Wendisch M; Bornhäuser M; Bachmann M; Rieber EP; Schmitz M
    Leukemia; 2007 Jul; 21(7):1464-71. PubMed ID: 17495970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade).
    Arpinati M; Chirumbolo G; Nicolini B; Agostinelli C; Rondelli D
    Bone Marrow Transplant; 2009 Feb; 43(3):253-9. PubMed ID: 18806836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine protease Per a 10 from Periplaneta americana bias dendritic cells towards type 2 by upregulating CD86 and low IL-12 secretions.
    Goel C; Govindaraj D; Singh BP; Farooque A; Kalra N; Arora N
    Clin Exp Allergy; 2012 Mar; 42(3):412-22. PubMed ID: 22356142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation.
    Wang YS; Chi KH; Liao KW; Liu CC; Cheng CL; Lin YC; Cheng CH; Chu RM
    Can J Vet Res; 2007 Jul; 71(3):165-74. PubMed ID: 17695590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-stranded RNA stimulation or CD40 ligation of monocyte-derived dendritic cells as models to study their activation and maturation process.
    Megiovanni AM; Sanchez F; Gluckman JC; Rosenzwajg M
    Eur Cytokine Netw; 2004; 15(2):126-34. PubMed ID: 15319172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta5-subunit.
    Blackburn C; Gigstad KM; Hales P; Garcia K; Jones M; Bruzzese FJ; Barrett C; Liu JX; Soucy TA; Sappal DS; Bump N; Olhava EJ; Fleming P; Dick LR; Tsu C; Sintchak MD; Blank JL
    Biochem J; 2010 Sep; 430(3):461-76. PubMed ID: 20632995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line.
    Lü S; Yang J; Song X; Gong S; Zhou H; Guo L; Song N; Bao X; Chen P; Wang J
    J Pharmacol Exp Ther; 2008 Aug; 326(2):423-31. PubMed ID: 18502982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells.
    Nencioni A; Garuti A; Schwarzenberg K; Cirmena G; Dal Bello G; Rocco I; Barbieri E; Brossart P; Patrone F; Ballestrero A
    Eur J Immunol; 2006 Mar; 36(3):681-9. PubMed ID: 16479541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the proteasome influences murine and human dendritic cell development in vitro and in vivo.
    Zinser E; Rössner S; Littmann L; Lüftenegger D; Schubert U; Steinkasserer A
    Immunobiology; 2009; 214(9-10):843-51. PubMed ID: 19628298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132.
    Crawford LJ; Walker B; Ovaa H; Chauhan D; Anderson KC; Morris TC; Irvine AE
    Cancer Res; 2006 Jun; 66(12):6379-86. PubMed ID: 16778216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking.
    Peiser M; Wanner R; Kolde G
    J Leukoc Biol; 2004 Sep; 76(3):616-22. PubMed ID: 15178702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous extract of Phyllanthus niruri (Euphorbiaceae) enhances the phenotypic and functional maturation of bone marrow-derived dendritic cells and their antigen-presentation function.
    Nworu CS; Akah PA; Okoye FB; Esimone CO
    Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):393-401. PubMed ID: 20095802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation.
    Nencioni A; Schwarzenberg K; Brauer KM; Schmidt SM; Ballestrero A; Grünebach F; Brossart P
    Blood; 2006 Jul; 108(2):551-8. PubMed ID: 16537813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.